sellWeak cluster of 210b5-1 plan
Carl Dambkowski sold $143k of APGE
Chief Medical Officer at Apogee Therapeutics, Inc.. 3,520 shares at an average of $40.69, traded Feb 5, 2025, filed Feb 7, 2025.
Warning score
0Value
$143k
3,520 shares
Holdings after
252,623
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +11Trade size$143k at market
- 0Share of holdings soldSold 1.4% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-25-010645, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 5, 2025 | MOption exercise Common Stock10b5-1 | +795 | $22.86 | $18k | 256,143 | Feb 7, 2025 |
| Feb 5, 2025 | SOpen-market sale Common Stock10b5-1 | -3,520 | $40.69 | $143k | 252,623 | Feb 7, 2025 |
| Feb 5, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -795 | $0.00 | $0 | 171,375 | Feb 7, 2025 |
Related signals
Other insiders at Apogee Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $103k 2,725 shares | -1% | |
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $103k 2,725 shares | -1% | |
| 0Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $455k 10,090 shares | -4% | |
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $101k 2,725 shares | -1% | |
| 5Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $97k 2,725 shares | -1% | |
| 6Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $140k 3,860 shares | -2% | |
| 27Weak | Apogee Therapeutics, Inc. | Michael Thomas Henderson Chief Executive Officer | $302k 10,000 shares | -1% | |
| 10Weak | Apogee Therapeutics, Inc. | Carl Dambkowski Chief Medical Officer | $48k 1,590 shares | -1% | |
| 33Weak | Apogee Therapeutics, Inc. | Michael Thomas Henderson Chief Executive Officer | $609k 15,000 shares | -1% | |
| 34Weak | Apogee Therapeutics, Inc. | Michael Thomas Henderson Chief Executive Officer | $733k 15,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.